These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24237668)

  • 1. Detection of common mutations in sporadic primary localized cutaneous amyloidosis by DNA mass spectrometry.
    Chang YT; Lin CH; Lee CT; Lin MW; Liu LY; Chen CC; Lee DD; Liu HN; Tsai SF; Matsuura I
    Br J Dermatol; 2014 Apr; 170(4):974-6. PubMed ID: 24237668
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial primary localized cutaneous amyloidosis results from either dominant or recessive mutations in OSMR.
    Wali A; Liu L; Takeichi T; Jelani M; Rahman OU; Heng YK; Thng S; Lee J; Akiyama M; McGrath JA; Betz RC
    Acta Derm Venereol; 2015 Nov; 95(8):1005-7. PubMed ID: 25792357
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and genetic features of Chinese patients with lichen and macular primary localized cutaneous amyloidosis.
    Lu P; Wu FF; Rong ZL; Fang C; Deng CC; Bin LH; Yang B
    Clin Exp Dermatol; 2019 Jun; 44(4):e110-e117. PubMed ID: 30734345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences of Chinese patients with primary localized cutaneous amyloidosis.
    Lu P; Wu F; Man M; Rong Z; Zhang Y; Yang B
    J Dermatol; 2019 Jul; 46(7):e242-e243. PubMed ID: 30740762
    [No Abstract]   [Full Text] [Related]  

  • 5. [Identification of pathogenic mutations in two Chinese families affected with primary localized cutaneous amyloidosis].
    Mao B; Yao X; Wang Z; Zhao X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):9-13. PubMed ID: 29419851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial primary localized cutaneous amyloidosis in a Japanese family.
    Ueo D; Utani A; Okubo Y; Yozaki M; Mine Y; Anan T; Nishida H; Takahashi D; Sakai T; Hatano Y; Fujiwara S
    J Dermatol Sci; 2016 Aug; 83(2):162-4. PubMed ID: 27289340
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel oncostatin M/interleukin-31 receptor mutation in familial primary localized cutaneous amyloidosis.
    Adams R; Colmont C; Mukhtar A; Morgan H; Patel GK
    Clin Exp Dermatol; 2020 Mar; 45(2):254-256. PubMed ID: 31478212
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial primary localized cutaneous amyloidosis with an oncostatin M receptor-β mutation, Pro694Leu.
    Schreml S; Weber BH; Schröder J; Siegmund H; Schaller J; Vogt T; Landthaler M; Schönbuchner I; Röcken C; Babilas P
    Clin Exp Dermatol; 2013 Dec; 38(8):932-5. PubMed ID: 23692662
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis.
    Lin MW; Lee DD; Liu TT; Lin YF; Chen SY; Huang CC; Weng HY; Liu YF; Tanaka A; Arita K; Lai-Cheong J; Palisson F; Chang YT; Wong CK; Matsuura I; McGrath JA; Tsai SF
    Eur J Hum Genet; 2010 Jan; 18(1):26-32. PubMed ID: 19690585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.
    Qi XP; Zhao JQ; Chen ZG; Cao JL; Du J; Liu NF; Li F; Sheng M; Fu E; Guo J; Jia H; Zhang YM; Ma JM
    Oncotarget; 2015 Oct; 6(32):33993-4003. PubMed ID: 26356818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel OSMR mutation in familial primary localized cutaneous amyloidosis in a Japanese family.
    Arita K; Abe R; Baba K; McGrath JA; Akiyama M; Shimizu H
    J Dermatol Sci; 2009 Jul; 55(1):64-5. PubMed ID: 19375894
    [No Abstract]   [Full Text] [Related]  

  • 12. LC-MS/MS and immuno-electron subtyping combined with genetics show that OSMR mutations cause amyloid deposition of keratins 5/14 in familial primary localized cutaneous amyloidosis.
    Bourguiba R; Bachmeyer C; Moguelet P; Kaaki S; Ory C; Touchard G; Cattan E; Georgin-Lavialle S; Colombat M; Valleix S
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e66-e68. PubMed ID: 34459039
    [No Abstract]   [Full Text] [Related]  

  • 13. A Th2 cytokine interleukin-31 signature in a case of sporadic lichen amyloidosis.
    Dousset L; Seneschal J; Boniface K; Charreau S; Ezzedine K; Milpied B; Mossalayi MD; McGrath JA; Lecron JC; Taïeb A
    Acta Derm Venereol; 2015 Feb; 95(2):223-4. PubMed ID: 24573820
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oncostatin M receptor beta mutations in familial primary localised cutaneous amyloidosis].
    Dereure O
    Ann Dermatol Venereol; 2008 Oct; 135(10):718-9. PubMed ID: 18929930
    [No Abstract]   [Full Text] [Related]  

  • 15. Semidominant GPNMB Mutations in Amyloidosis Cutis Dyschromica.
    Onoufriadis A; Hsu CK; Eide CR; Nanda A; Orchard GE; Tomita K; Sheriff A; Scott W; Tierney C; Lee JYW; Gomaa NS; Desomchoke R; Lwin SM; Tu WT; Chen LY; Huang HY; Chao SC; Yu-Yun Lee J; Bare Y; Hayday T; Guy AL; Liu L; Lees C; Hirdler T; Lovell P; Xia L; Dayrit JF; Calonje E; Simpson MA; Tolar J; Parsons M; McGrath JA
    J Invest Dermatol; 2019 Dec; 139(12):2550-2554.e9. PubMed ID: 31226264
    [No Abstract]   [Full Text] [Related]  

  • 16. A new c.1845A→T of oncostatin M receptor-β mutation and slightly enhanced oncostatin M receptor-β expression in a Chinese family with primary localized cutaneous amyloidosis.
    Wang WH; Li LF; Huang ES; Zhang Q; Sun TT; Song QH; Xu ML; Chen XR
    Eur J Dermatol; 2012; 22(1):29-33. PubMed ID: 22062952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an oncostatin M receptor mutation associated with familial primary cutaneous amyloidosis.
    Babilas P; Fiebig BS; Aslanidis C; Hansen J; Röcken C; Schroeder J; Schmitz G; Weber BH; Landthaler M; Vogt T
    Br J Dermatol; 2009 Oct; 161(4):944-7. PubMed ID: 19466957
    [No Abstract]   [Full Text] [Related]  

  • 18. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis.
    Tanaka A; Arita K; Lai-Cheong JE; Palisson F; Hide M; McGrath JA
    Br J Dermatol; 2009 Dec; 161(6):1217-24. PubMed ID: 19663869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis.
    Arita K; South AP; Hans-Filho G; Sakuma TH; Lai-Cheong J; Clements S; Odashiro M; Odashiro DN; Hans-Neto G; Hans NR; Holder MV; Bhogal BS; Hartshorne ST; Akiyama M; Shimizu H; McGrath JA
    Am J Hum Genet; 2008 Jan; 82(1):73-80. PubMed ID: 18179886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients.
    Liu J; Chen J; Zhong Y; Yu X; Lu P; Feng J; Zhang X; Ma S; Yang C; Yang B; Rong Z
    Protein Cell; 2021 Aug; 12(8):653-661. PubMed ID: 33502684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.